Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Jocelyn A. Ricard

17 indexed publications match this author name.

ORCID: 0000-0001-9605-9389
OpenAlex: https://openalex.org/A5000608905

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Toxicity 6 Depression 5 Clinical Trial 5 Pharmacology 5 Safety 4 Observational Study 3 General 3 Treatment-Resistant Depression 2 Animal Study 2 In Vitro Study 2 Drug Interactions 2 Mechanism of Action 2

Journals

Science Letters 3 Toxicology Letters 3 RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia 3 Psychotherapy and Psychosomatics 1 JAMA Psychiatry 1 Instituto Politécnico do Porto 1 Frontiers in Psychiatry 1 Scientific Reports 1

Publication history

Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-26 Impact of psilocybin and Psilocybe cubensis extract on gut microbiota in Wistar Han ratsScience Letters · 2026-04-16 Psilocybin and Psilocybe cubensis extract exhibit divergent behavioural and toxicological effects in ratsScience Letters · 2026-04-16 Investigating Psychedelic Tryptamines: Extraction and Quantification from Psilocybe MushroomsScience Letters · 2026-04-16 Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-03-17 Psilocin as a Broad Inhibitor of CYP450 Enzymes: Integrated In Vitro and In Silico EvidenceInstituto Politécnico do Porto · 2026-02-24 Race and ethnicity moderate the associations between lifetime psilocybin use and past year hypertensionFrontiers in Psychiatry · 2024-06-23 P05-02: Assessment of the CYP450 inhibitory activity of psilocybin, psilocin, LSD, 5-MeO-DMT and mescaline: An in vitro studyToxicology Letters · 2023-08-31 P03-21 Magic mushrooms and psilocybin: pharmacokinetics, pharmacodynamics, and clinical applicationsToxicology Letters · 2022-08-31 P03-18 Simultaneous detection and quantification of psilocybin and psilocin by gas chromatography coupled to mass spectrometry (GC-MS)Toxicology Letters · 2022-08-31 Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample.Scientific Reports · 2022-04-06 Production and extraction of psilocybin and psilocin from Psilocybe spp. mushroomsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-05 Evaluation of a quantitative analytical method for psilocin and psilocybin using HPLC-DADRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-05 Psylocybin and Psilocin as new tools to fight depression: an overview of the Pharmacodynamic and pharmacokinetic mechanismsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-05 Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.Neuroscience Applied · 2022-03-06 The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility.Journal of Psychopharmacology · 2022-02-28 P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current statusEuropean Neuropsychopharmacology · 2021-11-30

Author directory